Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells

Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells

The most conserved molecular phenotype of Fragile X Syndrome (FXS) is aberrant protein synthesis. This has been validated in a variety of experimental model systems from zebrafish to rats, patient-derived lymphoblasts and fibroblasts. With the advent of personalized medicine paradigms, patient-deriv...

Full description

Bibliographic Details
Main Authors:	Rakhi Pal, Aditi Bhattacharya
Format:	Article
Language:	English
Published:	MDPI AG 2019-03-01
Series:	Brain Sciences
Subjects:	protein synthesis Fragile X Syndrome biomarker iPSC fibroblast lymphoblast
Online Access:	http://www.mdpi.com/2076-3425/9/3/59

Similar Items

Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome
by: Mittal Jasoliya, et al.
Published: (2020-06-01)

Direct conversion from skin fibroblasts to functional dopaminergic neurons for biomedical application
by: Yongwoo Jang, et al.
Published: (2017-10-01)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
by: Guang Yang, et al.
Published: (2018-09-01)

Síndrome frágil X Fragile X syndrome
by: Miguel Lugones Botell, et al.
Published: (2006-09-01)

Cardiomyocytes Derived from Induced Pluripotent Stem Cells as a Disease Model for Propionic Acidemia
by: Esmeralda Alonso-Barroso, et al.
Published: (2021-01-01)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
by: Francis Grafton, et al.
Published: (2021-08-01)

Auditory Processing in Fragile X Syndrome
by: Sarah E Rotschafer, et al.
Published: (2014-02-01)

Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer’s Disease-Associated Presenilin 1 Mutation
by: Patricia Martín-Maestro, et al.
Published: (2017-09-01)

Induced pluripotent stem cell (iPSC) line MLi-004A derived from a patient with recessive dystrophic epidermolysis bullosa (RDEB)
by: Sandra Ropret, et al.
Published: (2021-08-01)

Molecular Biomarkers in Fragile X Syndrome
by: Marwa Zafarullah, et al.
Published: (2019-04-01)

Electroretinography and contrast sensitivity, complementary translational biomarkers of sensory deficits in the visual system of individuals with fragile X syndrome
by: Olivier Perche, et al.
Published: (2021-10-01)

Neuroanatomy of Fragile X Syndrome
by: J Gordon Millichap
Published: (1991-02-01)

Fragile-X Syndrome
by: J Gordon Millichap
Published: (1988-03-01)

Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
by: Shin Kawamata, et al.
Published: (2015-01-01)

Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome
by: Zhong-Hua Liu, et al.
Published: (2012-03-01)

Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
by: Ernesto Manzo, et al.
Published: (2019-06-01)

Impact of Fragile X Syndrome on Their Families
by: Concha Iriarte-Redín, et al.
Published: (2020-12-01)

Síndrome frágil X Fragile X Syndrome
Published: (2007-03-01)

Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance
by: Lauren E. Ethridge, et al.
Published: (2019-10-01)

Diagnosis of Fragile X Syndrome
by: J Gordon Millichap
Published: (1991-12-01)

Fragile X Syndrome
by: J Gordon Millichap
Published: (1987-11-01)

Fragile X Syndrome
by: Ninlapa Pruksanusak, et al.
Published: (2012-06-01)

Geração de célula-tronco pluripotente canina: fatores envolvidos no estabelecimento da reprogramação por indução gênica
by: Natalia Juliana Nardelli Gonçalves
Published: (2015)

Geração de célula-tronco pluripotente canina: fatores envolvidos no estabelecimento da reprogramação por indução gênica
by: Gonçalves, Natalia Juliana Nardelli
Published: (2015)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
by: Sherida de Leeuw, et al.
Published: (2019-07-01)

IPSC-derived trophoblasts: a novel model for infections at the maternal fetal interface
by: Wang, Jennifer
Published: (2020)

Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome
by: Anke Van Dijck, et al.
Published: (2020-04-01)

Panobinostat Effectively Increases Histone Acetylation and Alters Chromatin Accessibility Landscape in Canine Embryonic Fibroblasts but Does Not Enhance Cellular Reprogramming
by: Maryam Moshref, et al.
Published: (2021-09-01)

Visual processing deficits in the Fragile X Syndrome
by: Kogan, Cary Samuel
Published: (2005)

Modeling Fragile X Syndrome in Drosophila
by: Małgorzata Drozd, et al.
Published: (2018-04-01)

Autophagy pathway upregulation in a human iPSC-derived neuronal model of Cohen syndrome with VPS13B missense mutations
by: You-Kyung Lee, et al.
Published: (2020-05-01)

Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene
by: Huifang Zhao, et al.
Published: (2020-07-01)

Induced pluripotent stem cell models of myeloid malignancies and clonal evolution
by: Andreea Reilly, et al.
Published: (2021-04-01)

Towards Mechanism-based Treatments for Fragile X Syndrome
Published: (2019)

Dual Function of iPSC-Derived Pericyte-Like Cells in Vascularization and Fibrosis-Related Cardiac Tissue Remodeling In Vitro
by: Monika Szepes, et al.
Published: (2020-11-01)

Fragile X syndrome: clinical, electroencephalographic and neuroimaging characteristics Síndrome do X frágil: características clínicas, eletrencefalográficas e de imagem
by: MARILISA M. GUERREIRO, et al.
Published: (1998-03-01)

Early Diagnosis of Fragile X Syndrome
by: J Gordon Millichap
Published: (2003-02-01)

Epilepsy and Fragile X Syndrome
by: J Gordon Millichap
Published: (2003-01-01)

Fragile X Syndrome Recognition
by: J Gordon Millichap
Published: (1989-02-01)

Fragile X Females and Psychiatric Disorders
by: J Gordon Millichap
Published: (1993-03-01)